AP3B1 and hemophagocytic syndrome: Several monogenic defects that primarily manifest with HLH development, including PRF1, UNC13D, STX11, STXBP2, RAB27A, LYST, and AP3B1, are considered as “primary HLH.” These patients need HSCT for complete disease cure.